首页> 外文会议> >Implantable parylene MEMS for glaucoma therapy
【24h】

Implantable parylene MEMS for glaucoma therapy

机译:用于青光眼治疗的植入式聚对二甲苯MEMS

获取原文

摘要

An implantable glaucoma management system is presented for the first time. Glaucoma is an incurable disease characterized by gradual visual field loss that eventually results in blindness. Studies indicate that reduction of intraocular pressure reduces the rate of disease progress. A passive parylene MEMS pressure sensor and drainage shunt comprise a complete system for the detection and alleviation of elevated intraocular pressure. Tissue anchors for securing the pressure sensor to the iris have been developed to facilitate direct and convenient optical monitoring of intraocular pressure.
机译:首次提出了植入式青光眼管理系统。青光眼是一种无法治愈的疾病,其特征是逐渐丧失视野,最终导致失明。研究表明,降低眼内压会降低疾病进展的速度。被动式聚对二甲苯MEMS压力传感器和排水分流器组成了一个完整的系统,用于检测和缓解眼内压升高。已经开发出用于将压力传感器固定到虹膜的组织锚,以促进直接和方便的眼内压的光学监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号